Ranbaxy Labs Sep '11 sales at Rs 1,425.06 crore
Published on Thu, Nov 10, 2011 at 19:15 | Source : Moneycontrol.com
40048 Investors following Ranbaxy Labs. Share this News with them.
 0
Like this story, share it with millions of investors on M3
Ranbaxy Labs Sep '11 sales at Rs 1,425.06 crore
Ranbaxy Laboratories has reported a sales turnover of Rs 1,425.06 crore and a net loss of Rs 439.20 crore for the quarter ended Sep '11
Ranbaxy Laboratories has reported a sales turnover of Rs 1,425.06 crore and a net loss of Rs 439.20 crore for the quarter ended Sep '11.
| For the quarter ended Sep 2010 the sales turnover was Rs 1,181.05 crore and net profit was Rs 221.77 crore.
|
| | | Quarterly Results of Ranbaxy Laboratories | -------- in Rs. Cr. -------- |
| | Sep '10 | | | Jun '11 | Sep '11 | | Sales Turnover | 1,181.05 | | | 1,282.02 | 1,425.06 | | Other Income | 177.22 | | | 44.74 | 104.20 | | Total Income | 1,358.27 | | | 1,326.76 | 1,529.26 | | Total Expenses | 1,157.63 | | | 1,213.40 | 1,495.76 | | Operating Profit | 23.42 | | | 68.62 | -70.70 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | 98.48 | | | 186.70 | -400.15 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 200.64 | | | 113.36 | 33.50 | | Interest | 9.57 | | | 14.83 | 14.24 | | PBDT | 289.55 | | | 191.88 | -380.89 | | Depreciation | 45.47 | | | 46.98 | 49.31 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 244.08 | | | 144.90 | -430.20 | | Tax | 22.31 | | | -5.48 | 9.00 | | Net Profit | 221.77 | | | 150.38 | -439.20 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 5.27 | | | 3.57 | -- | | Book Value | -- | | | -- | -- | | Equity | 210.38 | | | 210.68 | 210.75 | | Reserves | -- | | | -- | -- | | Face Value | 5.00 | | | 5.00 | 5.00 | | Source : Dion Global Solutions Limited |
|
Trending News
Business News
- Better global cues helped market absorb GDP shock Udayan
- GDP growth slips below 2008 crisis level CRISIL
- Weak GDP number not a shocker Sanju Verma
- Wall St to open slightly lower after jobs, GDP data
- Mkts recover despite dismal GDP data;Sensex closes 94pts lower
- Industry demands package to revive economic growth
- Godrej asks for RBI rate cuts after weak GDP growth
- Citi cuts FY13 GDP forecast to 6.4% from 7%
- Precious, base metals may come under pressure today Angel
- Oil down near $103, eyes worst month in 2 yrs
- Govt will take steps to improve growth FM
- Govt launches austerity drive, bans meetings in 5-stars
- Govt relaxes norms for dvpt fund release for J&K, NE states
- Management Tip of the Day Don't take that coffee break
- April industry, services sector loan growth slows RBI
- India announces austerity measures, cuts non-plan spend
- ECB, EU officials warn euro's survival at risk
- Spicejet to get first ATF shipment early July CEO
- Reliance Power, Shell in JV for LNG terminal
- Reliance Power, Shell in JV for India LNG terminal
|
Prakash Javadekar CNBC-TV18 Exclusive Will Be Happy If A Probe In The Matter Has Been Ordered
The latest earning numbers FIRST on CNBC-TV18
Subscribe to
Moneycontrol Newsletters
|
